Initiation of this therapy has shown to result in dramatic infiltration of CD8+ T cells in tumor tissue with subsequent cell apoptosis, which likely results dually from pathways downstream of chimeric death receptor in addition to immunogenic viral epitopes that stimulate immune targeting (134). Here, CD8A is linked to neoplasm.